AKT1 and depressive symptom measurement: Ginsenoside Rb1 exerts neuroprotective, anti-obesity, and anti-depression effects by suppressing different inflammatory pathways, including oxidative stress, the NF-ĸB/MAPK pathway, the AKT pathway, and amyloidogenic processes [76,77,78].